{"altmetric_id":1686515,"counts":{"readers":{"mendeley":43,"citeulike":0,"connotea":0},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["Magil2006","mtmdphd"],"posts_count":4}},"selected_quotes":["@beabernardez La leer\u00e9 con calma. me pregunto al ver cosas como enlace, si tras ello no vendr\u00e1 el HRAS BRAF?","@jgasquet, tras el nras\u00bf vendr\u00e1 e HRAS el BRAF.....? \u00bfExisten discordancias entre el primario y la reca\u00edda?","FOLFOXIRI + panitumumab 1st-line Tx in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) met colorectal CA Pts #crcsm","Does 'Fantastic' CRC Response Herald a New Era? Fonaro et al Ann Oncol: cc: @SKopetz #crcsm"],"citation":{"abstract":"The FOLFOXIRI regimen developed by the Gruppo Oncologico Nord Ovest (GONO) demonstrated higher activity and efficacy compared with FOLFIRI in metastatic colorectal cancer (mCRC). Panitumumab is effective in some patients with KRAS codon 12-13 wild-type mCRC. KRAS codon 61, HRAS, NRAS, and BRAF V600E mutations might predict resistance to anti-epidermal growth factor receptor antibodies.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f610002280","authors":["Fornaro L","Lonardi S","Masi G","Loupakis F","Bergamo F","Salvatore L","Cremolini C","Schirripa M","Vivaldi C","Aprile G","Zaniboni A","Bracarda S","Fontanini G","Sensi E","Lupi C","Morvillo M","Zagonel V","Falcone A"],"doi":"10.1093\/annonc\/mdt165","first_seen_on":"2013-08-13T18:09:23+00:00","issns":["0923-7534"],"issue":"","journal":"Annals of Oncology","last_mentioned_on":1379237163,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23666916","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/23666916\/"],"pmid":"23666916","pubdate":"2013-05-16T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO).","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/folfoxiri-combination-panitumumab-firstline-treatment-quadruple-wildtype-kras-nras-hras-braf-metasta"},"altmetric_score":{"score":0.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.75},"context_for_score":{"all":{"total_number_of_other_articles":4507280,"mean":5.1336924524522,"rank":2918720,"this_scored_higher_than_pct":31,"this_scored_higher_than":1438377,"rank_type":"exact","sample_size":4507280,"percentile":31},"similar_age_3m":{"total_number_of_other_articles":90533,"mean":7.6539335925421,"rank":58076,"this_scored_higher_than_pct":32,"this_scored_higher_than":29491,"rank_type":"exact","sample_size":90533,"percentile":32},"this_journal":{"total_number_of_other_articles":2299,"mean":4.9995735422106,"rank":1690,"this_scored_higher_than_pct":22,"this_scored_higher_than":522,"rank_type":"exact","sample_size":2299,"percentile":22},"similar_age_this_journal_3m":{"total_number_of_other_articles":31,"mean":4.7352666666667,"rank":26,"this_scored_higher_than_pct":16,"this_scored_higher_than":5,"rank_type":"exact","sample_size":31,"percentile":16}}},"demographics":{"poster_types":{"researcher":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Scientists":1}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Librarian":1,"Student  > Doctoral Student":1,"Researcher":18,"Student  > Ph. D. Student":4,"Student  > Postgraduate":2,"Other":8,"Student  > Bachelor":7},"by_discipline":{"Medicine and Dentistry":29,"Social Sciences":2,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":7,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"US":1},"mendeley":{"EC":2,"UY":1,"US":1,"GB":1,"EE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Magil2006\/status\/379174260860018688","license":"public","citation_ids":[1686515],"posted_on":"2013-09-15T09:26:03+00:00","author":{"name":"Mari\u00e1ngel Gil","image":"https:\/\/pbs.twimg.com\/profile_images\/760498520252149760\/Obcoy5Is_normal.jpg","description":"Los que me conoc\u00e9is ya sab\u00e9is, los que ya sab\u00e9is no me conoc\u00e9is. Botica del hospital y otras inquietudes.","id_on_source":"Magil2006","tweeter_id":"921568016","geo":{"lt":null,"ln":null},"followers":643},"tweet_id":"379174260860018688"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/367347097533964288","license":"public","citation_ids":[1686515],"posted_on":"2013-08-13T18:09:07+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15354},"tweet_id":"367347097533964288"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/367351212209090560","license":"public","citation_ids":[1686515],"posted_on":"2013-08-13T18:25:28+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15354},"tweet_id":"367351212209090560"},{"url":"http:\/\/twitter.com\/Magil2006\/status\/377930051205234688","license":"public","citation_ids":[1686515],"posted_on":"2013-09-11T23:02:00+00:00","author":{"name":"Mari\u00e1ngel Gil","image":"https:\/\/pbs.twimg.com\/profile_images\/760498520252149760\/Obcoy5Is_normal.jpg","description":"Los que me conoc\u00e9is ya sab\u00e9is, los que ya sab\u00e9is no me conoc\u00e9is. Botica del hospital y otras inquietudes.","id_on_source":"Magil2006","tweeter_id":"921568016","geo":{"lt":null,"ln":null},"followers":643},"tweet_id":"377930051205234688"}]}}